BRCA1 and breast carcinoma: For the unaffected group, however, we hypothesize that these results may be explained by a limited perception of the actual risk of developing breast cancer among carriers of P/LP variants in BRCA1/2 genes, potentially due to the absence of effective consent discussions and risk communication with healthcare providers.